Journal
JOURNAL OF CLINICAL MICROBIOLOGY
Volume 59, Issue 1, Pages -Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.02148-20
Keywords
emergency use authorization; antibody; serology; severe acute; respiratory syndrome coronavirus 2; verification
Categories
Funding
- Ortho-Clinical Diagnostics
- BioFire
Ask authors/readers for more resources
This document presents expert recommendations on detailed verification strategies, limitations, reporting considerations, and types of antibody detection assays for SARS-CoV-2 serologic testing with FDA EUA. It also includes discussions on additional considerations prior to assay implementation, such as biosafety, quality control, and proficiency testing strategies, providing updated guidance for laboratorians in the rapidly changing landscape of SARS-CoV-2 serologic testing.
Interest continues to grow regarding the role of serologic assays for the detection of prior infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) status to many SARS-CoV-2 serologic assays. In this document, expert recommendations from clinical microbiologist members of the American Society for Microbiology (ASM) concerning detailed verification strategies for SARS-CoV-2 serologic assays with FDA EUA are provided, as are insights into assay limitations and reporting considerations for laboratories. Assessments concerning single-antibody and multiantibody isotype detection assays, which may provide either differentiated or nondifferentiated (i.e., total antibody) antibody class results, are addressed. Additional considerations prior to assay implementation are also discussed, including biosafety, quality control, and proficiency testing strategies. As the landscape of SARS-CoV-2 serologic testing is rapidly changing, this document provides updated guidance for laboratorians on application of these assays.Y
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available